2010, Número 3
<< Anterior Siguiente >>
Med Int Mex 2010; 26 (3)
La enigmática respuesta isotópica de Wolf. Casos de esta visible dupla y su revisión
Eduardo PD, Muñoz SR, Fernández RM
Idioma: Español
Referencias bibliográficas: 54
Paginas: 286-292
Archivo PDF: 284.22 Kb.
RESUMEN
Se conoce como respuesta isotópica de Wolf a los diversos procesos dermatológicos que pueden ocurrir como nueva enfermedad en un mismo sitio donde ocurrió otra no relacionada, y ya aliviada. Sucede con mayor frecuencia tras un herpes zóster. Pueden ser de índole infecciosa, granulomatosa o tumoral. En ocasiones aparecen en pacientes diabéticos, inmunosuprimidos con neoplasias o infección por el virus de la inmunodeficiencia humana (VIH), pero otros pacientes no muestran enfermedad subyacente alguna. El intervalo entre la primera y la segunda afección es variable, entre días y años, y sus diversas explicaciones fisiopatogénicas aún se prestan a debate.
REFERENCIAS (EN ESTE ARTÍCULO)
Diccionario Panhispánico de Dudas. Real Academia Española/ Asociación de Academias de la lengua española. 1a ed. Bogotá: Aguilar, Altea, Taurus, Alfaguara, 2005;p:377.
Wyburn-Mason R. Malignant change arising in tissues affected by herpes. BMJ 1955;2:1106-1109.
Wolf R, Brenner S, Ruocco V, et al. Isotopic response. Int J Dermatol 1995;34:341-348.
Ruocco V, Wolf R, Filioli FG. La reponse homotopique en Dermatologie. Annals Derm Venereol 1997;124(4):333.
Shurman D, Reich HL, James WD. Lichen planus confined to a radiation field: The “isoradiotopic” response. J Am Acad Dermatol 2004;50(3):482-483.
Sharma RC, Sharma NL, Mahajan V, et al. Wolf’s isotopic response: Herpes simplex appearing on scrofuloderma scar. Int J Dermatol 2003;42:664-666.
Bolognia, JL, Jorizzo JL, Rapini RP, et al. Dermatology. 2nd ed. London: Mosby-Elsevier, 2008;pp:917,1199-1194,1204-1208.
Straus SE, Oxman MN, Schmader KE. Varicela y herpes zoster. En: Wolff K, Goldsmith LA, Katz S y col., editores. Fitzpatrick Dermatología en Medicina General. 7ª ed. Buenos Aires: Médica Panamericana, 2008;pp:862-8,1885-1898.
Ruocco V, Ruocco E, Ghersetich I, et al. Isotopic response after herpes virus infection: an update. J Am Acad Dermatol 2002;46:90-94.
Requena L, Kutzner H, Escalonilla P, et al. Cutaneous reaction at sites of herpes zoster scars: an expanded spectrum. Br J Dermatol 1998;138:161-168.
White GM, Cox NH. Diseases of the skin, a color atlas and text. 2nd ed. Philadelphia: Mosby-Elsevier, 2006;pp:525-539.
Del Rio E, Allegue F, Vazquez Veiga AH. Comedones appearing after herpes zoster infection: a report of 7 cases. Arch Dermatol 1997;133:1316-1317.
Weidman F, Boston LN. Generalized xanthoma tuberosum with xanthomatous changes in fresh scars of intercurrent zoster. Arch Intern Med 1937;59:793-822.
Guill MA, Goette DK. Granuloma annulare at site of healing herpes zoster. Arch Dermatol 1978;114:1383.
Packer RH, Fields JP, King LE. Granuloma annulare in herpes zoster scars. Cutis 1984;34:177-179.
Friedman SJ, Fox BJ, Albert HL. Granuloma annulare arising in herpes zoster scars: report of two cases and review of the literature. J Am Acad Dermatol 1986;14:764-770.
Bisaccia E, Scarborough DA, Carr RD. Cutaneous sarcoid granuloma formation in herpes zoster scars. Arch Dermatol 1983;119:788-789.
Olalquiaga J, Minano R, Barrio J, et al. Granuloma tubercoloide post-herpético en un paciente con leucemia linfocítica crónica. Med Cutan Ibero Lat Am 1995;23:113-115.
Langenberg A, Yen B, LeBoit PE. Granulomatous vasculitis occurring after cutaneous herpes zoster despite absence of viral genome. J Am Acad Dermatol 1991;24:429-433.
Baalbaki SA, Malak JA, Al-Khars MAA, et al. Granulomatous vasculitis in herpes zoster scars. Int J Dermatol 1994;33:268- 269.
Serfling U, Penneys NS, Zhu WY, et al. Varicella-zoster virus DNA in granulomatous skin lesions following herpes zoster: a study by the polymerase chain reaction. J Cutan Pathol 1993;20:28-33.
Wolf R, Wolf D. Tinea in a site of healed herpes zoster (isoloci response) [letter]. Int J Dermatol 1985;24:539.
Stubbings JM, Goodfield MJD. An unusual distribution of an acneiform rash due to herpes zoster infection. Clin Exp Dermatol 1993;18:92-93.
Sánchez JL, Méndez RP. Cutaneous pseudolymphoma at the site of resolving herpes zoster. Arch Dermatol 1981;117:377.
Wolff HH, Wendt V, Winzer M. Cutaneous pseudolymphoma at the site of prior herpes zoster eruption. Arch Dermatol Res 1987;279(Suppl.):S52-S54.
Roo E, Villegas C, Lopez-Bran E, et al. Postzoster cutaneous pseudolymphoma. Arch Dermatol 1994;130:661-663.
Russel B. Psoriasis zosteriformis. Br J Dermatol 1950;62:314- 316.
Strick S, Hyman AB. Lichen planus in the site of a previous zoster eruption. Arch Dermatol 1961;84:509-510.
Gerritsen MJP, Gruintjes FWG, Andreissen MA, et al. Lichen simplex chronicus as a complication of herpes zoster. Br J Dermatol 1998;138:904-927.
Baselga E, Drolet BA, Segura AD, et al. Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genome. J Cutan Pathol 1996;23:576-581.
Mitsuhashi Y, Kondo S. Post-zoster eosinophilic dermatosis. Br J Dermatol 1997;136:465-466.
Bang SW, Kim YK, Whang KU. Acquired reactive perforating collagenosis: unilateral umbilicated papules along the lesions of herpes zoster. J Am Acad Dermatol 1997;36:778- 779.
Aloi FG, Appino A, Puiatti P. Lymphoplasmocytoid lymphoma arising in herpes zoster scars. J Am Acad Dermatol 1990;22:130-131.
Marzano AV, Berti E, Alessi E. Primary cutaneous B-cell lymphoma with a dermatomal distribution. J Am Acad Dermatol 1999;41:884-886.
Cerroni L, Zenahlik P, Kerl H. Specific cutaneous infiltrates of B cell chronic lymphocytic leukemia arising at the sites of herpes zoster and herpes simplex scars. Cancer 1995;76:26-31.
Bahadoran P, Lacour JP, Del Giudice P, et al. Localisation cutanée d’une leucémie lymphoïde chronique dans le territoire d’un zona. Ann Dermatol Venereol 1996;123:471-473.
Cerroni L, Kerl H. Cutaneous localization of B-cell chronic lymphocytic leukemia at the site of varicella/herpesvirus eruptions. J Am Acad Dermatol 1997;37:1022.
Niedt GW, Prioleau PG. Kaposi’s sarcoma in a dermatome previously involved by herpes zoster. J Am Acad Dermatol 1988;18:448-451.
Hudson CP, Hanno R, Callen JP. Cutaneous angiosarcoma in a site of healed herpes zoster. Int J Dermatol 1984;23:404-407.
Wyburn-Mason R. Malignant change arising in tissues affected by herpes. BMJ 1955;2:1106-1109.
Cecchi R, Brunetti L, Bartoli L, et al. Zosteriform skin metastases from breast carcinoma in association with herpes zoster. Int J Dermatol 1998;37:476-477.
Rocco E. Genital warts at the site of healed herpes progenitalis: the isotopic response. Int J Dermatol 2000;39:705-706.
Claudy AL, Chignol MC, Chardonnet Y. Detection of herpes simplex virus DNA in a cutaneous squamous cell carcinoma by in situ hybridization. Arch Dermatol Res 1989;281:333-335.
Kligman AM. An experimental review of poison ivy (Rhus) dermatitis. Arch Dermatol 1958;77:149-155.
Rocco V, Astarita C, Guerrera V, et al. Kaposi’s sarcoma on a lymphedematous immunocompromised limb. Int J Dermatol 1984;23:56-60.
Ebert MH. Histologic changes in sensory nerves of the skin in herpes zoster. Arch Dermatol Syphilol 1949;60:641-648.
Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol 1995;33:482-496.
Ackerman KD, Felten SY, Bellinger DL, et al. Noradrenergic sympathetic innervation of spleen and lymph nodes in relation to cellular compartments. In: Cinader B, Miller RG, editors. Progress in immunology, VI. Toronto: Academic Press, 1986;p:588-600.
Payan FG, Levine JD, Goetzl EJ. Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 1984;132:1601-1604.
Wolf K, Goldsmith LA, Katz SI, et al. Skin problems in amputees. In: Fitzpatrick’s Dermatology in general medicine, 7a ed. New York: McGraw-Hill Medical, 2008.
Atkin DH, Levine N, Walter FG. Single patch of hair at a denervated site in a patient with alopecia universalis. J Am Acad Dermatol 1997;37:796-797.
Amon U, Wolff HH. Healing of chronic atopic dermatitis lesions in skin areas of paraplegia after trauma. J Dermatol 1994;21:982-983.
Whimster IW. Nerve supply as a stimulator of the growth of tissues including skin. I. Human evidence. Clin Exp Dermatol 1978;3:221-240.
Lebwohl MG, Heymann WR, Berth-Jones J, et al. Treatment of skin disease, comprehensive therapeutic strategies. 3rd ed. Philadelphia: Mosby Elsevier, 2009;p:306-308.